Approval · Notice of Compliance 35476 · 2025
PIASKY: Notice of Compliance 35476
Issued June 4, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35476
- Date
- June 4, 2025
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PIASKY | 02558262 | Marketed |
Medicinal ingredients
- CROVALIMAB 340 MG per 2ML